{"id":"coly-mycin-m-injectable-product","safety":{"commonSideEffects":[{"rate":"10-50","effect":"Nephrotoxicity (acute kidney injury)"},{"rate":"5-30","effect":"Neurotoxicity (paresthesias, dizziness, vertigo)"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Colistin is a last-resort antibiotic primarily used against multidrug-resistant gram-negative bacteria, particularly Pseudomonas aeruginosa and Acinetobacter baumannii. It acts as a cationic surfactant that penetrates and destabilizes the outer and inner membranes of gram-negative bacteria. The injectable formulation (Coly Mycin M) is administered intravenously or intramuscularly for systemic infections.","oneSentence":"Colistin (polymyxin E) is a cyclic polypeptide antibiotic that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:42.097Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Multidrug-resistant gram-negative bacterial infections (Pseudomonas aeruginosa, Acinetobacter baumannii)"},{"name":"Serious infections in hospitalized patients unresponsive to other antibiotics"}]},"trialDetails":[{"nctId":"NCT06198764","phase":"PHASE3","title":"A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-07-06","conditions":"Mental Health Issue","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Coly Mycin M Injectable Product","genericName":"Coly Mycin M Injectable Product","companyName":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","companyId":"chia-tai-tianqing-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Colistin (polymyxin E) is a cyclic polypeptide antibiotic that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death. Used for Multidrug-resistant gram-negative bacterial infections (Pseudomonas aeruginosa, Acinetobacter baumannii), Serious infections in hospitalized patients unresponsive to other antibiotics.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}